Gene · 5166
Papers3,136
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,136
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| lncRNA GAS5 suppresses rheumatoid arthritis by inhibiting miR-361-5p and increasing PDK4. | Biochem Biophys Res Commun | 2021 | 34715498 | PubTator, text mining | PubMed |
| Detection of Atherosclerosis by Small RNA-Sequencing Analysis of Extracellular Vesicle Enriched Serum Samples. | Front Cell Dev Biol | 2021 | 34712662 | PubTator, text mining | PubMed |
| Analysis and verification of N6-methyladenosine-modified genes as novel biomarkers for clear cell renal cell carcinoma. | Bioengineered | 2021 | 34699322 | PubTator, text mining | PubMed |
| Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral Targets. | Viruses | 2021 | 34696497 | PubTator, text mining | PubMed |
| Regulation of Cardiac-Specific Proteins Expression by Moderate-Intensity Aerobic Exercise Training in Mice With Myocardial Infarction Induced Heart Failure Using MS-Based Proteomics. | Front Cardiovasc Med | 2021 | 34692783 | PubTator, text mining | PubMed |
| Senescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age? | Front Pharmacol | 2021 | 34690759 | PubTator, text mining | PubMed |
| A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders. | Front Mol Neurosci | 2021 | 34690698 | PubTator, text mining | PubMed |
| The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man. | Molecules | 2021 | 34684760 | PubTator, text mining | PubMed |
Synthesis and Biological Evaluation of (S)-2-(Substituted arylmethyl)-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indole-3-carboxamide Analogs and Their Synergistic Effect against PTEN-Deficient MDA-MB-468 Cells. | Pharmaceuticals (Basel) | 2021 | 34681198 | PubTator, text mining | PubMed |
| Biofabrication of Artificial Stem Cell Niches in the Anterior Ocular Segment. | Bioengineering (Basel) | 2021 | 34677208 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cervical cancer and metabolomics perspectives. | Nutr Metab (Lond) | 2021 | 34666780 | PubTator, text mining | PubMed |
| Neuromedin B promotes chondrocyte differentiation of mesenchymal stromal cells via calcineurin and calcium signaling. | Cell Biosci | 2021 | 34663442 | PubTator, text mining | PubMed |
| Bioinformatic and experimental analyses of key biomarkers in pancreatic cancer. | Exp Ther Med | 2021 | 34659505 | PubTator, text mining | PubMed |
| Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism. | Front Oncol | 2021 | 34650913 | PubTator, text mining | PubMed |
| LncRNA SNHG12 promotes the development and progression of colon cancer by regulating the miR-15a/PDK4 axis. | Am J Transl Res | 2021 | 34650693 | PubTator, text mining | PubMed |
| A highly annotated database of genes associated with platinum resistance in cancer. | Oncogene | 2021 | 34645978 | PubTator, text mining | PubMed |
| Proteomic Landscape of Prostate Cancer: The View Provided by Quantitative Proteomics, Integrative Analyses, and Protein Interactomes. | Cancers (Basel) | 2021 | 34638309 | PubTator, text mining | PubMed |
| Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells. | Adv Sci (Weinh) | 2021 | 34632727 | PubTator, text mining | PubMed |
| Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications. | Front Bioeng Biotechnol | 2021 | 34631680 | PubTator, text mining | PubMed |
| PPAR-γ Modulators as Current and Potential Cancer Treatments. | Front Oncol | 2021 | 34631571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5166/papers?page=56